A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermecti... par Nicholas O Opoku, Felix Doe, Bettina Dubben, Nicole Fetcho, Kerstin Fischer, Peter U Fischer, Shelter Gordor, Charles W Goss, Michael E Gyasi, Achim Hoerauf, Augustine R Hong, Eric Kanza, Christopher L King, Ruth Laryea, Daphne Lew, Mahmood A Seidu, Gary J Weil

Accéder au texte intégral